Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;94(1):12-25.
doi: 10.1139/bcb-2015-0053. Epub 2015 Jul 7.

Connecting the dots: chromatin and alternative splicing in EMT

Affiliations
Review

Connecting the dots: chromatin and alternative splicing in EMT

Jessica A Warns et al. Biochem Cell Biol. 2016 Feb.

Abstract

Nature has devised sophisticated cellular machinery to process mRNA transcripts produced by RNA Polymerase II, removing intronic regions and connecting exons together, to produce mature RNAs. This process, known as splicing, is very closely linked to transcription. Alternative splicing, or the ability to produce different combinations of exons that are spliced together from the same genomic template, is a fundamental means of regulating protein complexity. Similar to transcription, both constitutive and alternative splicing can be regulated by chromatin and its associated factors in response to various signal transduction pathways activated by external stimuli. This regulation can vary between different cell types, and interference with these pathways can lead to changes in splicing, often resulting in aberrant cellular states and disease. The epithelial to mesenchymal transition (EMT), which leads to cancer metastasis, is influenced by alternative splicing events of chromatin remodelers and epigenetic factors such as DNA methylation and non-coding RNAs. In this review, we will discuss the role of epigenetic factors including chromatin, chromatin remodelers, DNA methyltransferases, and microRNAs in the context of alternative splicing, and discuss their potential involvement in alternative splicing during the EMT process.

Keywords: EMT; TEM; alternative splicing; cancer; chromatin; chromatine; epigenetics; épigénétique; épissage alternatif.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Interplay between chromatin remodelers, RNA Pol II and the splicing machinery during EMT
The kinetic model of alternative splicing posits that the spliceosome cannot keep up with the fast-moving RNA Pol II, therefore it has to choose between the splice sites presented to it and exon 2 (in this example) gets excluded. On the other hand, DNA methylation (represented by black lollipops), nucleosome positioning or histone modification changes, or microRNAs can all influence the rate of RNA Pol II elongation, slowing it down so that the spliceosome can now keep up with transcription. This results in all the exons being included. During EMT, many different types of slicing events can occur.
Figure 2
Figure 2. Examples of some splicing events during EMT
During EMT, many different types of slicing events occur. For example, p120 catenin switches from a short form to a longer form that includes additional exons. FGFR2 switches between isoforms containing two mutually exclusive exons, Exon IIIb or IIIc. CD44 produces multiple splice variants from 11 different exons, while after EMT, only the short variant (CD44s) is produced due to exon skipping.

Similar articles

Cited by

References

    1. Adami G, Babiss LE. DNA template effect on RNA splicing: two copies of the same gene in the same nucleus are processed differently. EMBO J. 1991;10(11):3457–3465. - PMC - PubMed
    1. Adams BD, Kasinski AL, Slack FJ. Aberrant regulation and function of microRNAs in cancer. Curr Biol. 2014;24(16):R762–76. doi: 10.1016/j.cub.2014.06.043. - DOI - PMC - PubMed
    1. Agranat-Tamir L, Shomron N, Sperling J, Sperling R. Interplay between pre-mRNA splicing and microRNA biogenesis within the supraspliceosome. Nucleic Acids Res. 2014;42(7):4640–4651. doi: 10.1093/nar/gkt1413. - DOI - PMC - PubMed
    1. Allemand E, Batsche E, Muchardt C. Splicing, transcription, and chromatin: a menage a trois. Curr Opin Genet Dev. 2008;18(2):145–151. doi: 10.1016/j.gde.2008.01.006. - DOI - PubMed
    1. Allo M, Buggiano V, Fededa JP, Petrillo E, Schor I, de la Mata M, Agirre E, Plass M, Eyras E, Elela SA, Klinck R, Chabot B, Kornblihtt AR. Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat Struct Mol Biol. 2009;16(7):717–724. doi: 10.1038/nsmb.1620. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources